Cooley has recruited a new partner in Shanghai who focuses on biotech and life science deals.

Yiming Liu is currently counsel with O’Melveny & Myers. He’s worked on several Hong Kong listings of Chinese biopharmaceutical companies in the past year. Most recently, he was part of a team that advised Jacobio Pharmaceuticals Co. on a $174 million Hong Kong initial public offering in December. In addition, he participated in at least four more Hong Kong listings of Chinese biotech companies in 2020.